A 48-year-old man with BMI 37 kg/m² and T2D seeks pharmacotherapy for obesity after lifestyle therapy. Which option is guideline-supported for long-te...

Question

A 48-year-old man with BMI 37 kg/m² and T2D seeks pharmacotherapy for obesity after lifestyle therapy. Which option is guideline-supported for long-term weight loss?

Accepted Answer

Use FDA-approved anti-obesity medications (e.g., GLP-1 RA) alongside lifestyle

Answer

Short-term phentermine only

Answer

Metformin monotherapy for weight loss

Answer

No role for medications

Answer

High-dose thyroid hormone

us-abfm MCQ (SBA): Obesity Management

A 48-year-old man with BMI 37 kg/m² and T2D seeks pharmacotherapy for obesity after lifestyle therapy. Which option is guideline-supported for long-term weight loss?